“These are adolescents suffering from certain pathologies, such as leukemia, chronic kidney or liver disease, Down’s syndrome, impaired immune system or transplant patients. When infected with the virus, they run a higher risk of complications leading to hospitalization “, specify the competent ministers of the different levels of power in a joint statement.
It is the doctor who decides whether or not his young patient falls into this category who will therefore soon be able to benefit from the vaccination against Covid-19. However, the ministers added a step: there must be consultation between the doctor and the parents and the child, and their consent must be clearly reflected in the medical file. We are only talking about a few thousand young people here, according to the CIM Santé.
Currently, only the product developed by BioNTech and Pfizer is authorized at European level for this age group. It is therefore this vaccine, in two doses, that these young adolescents will be administered.
For the general vaccination of all 12-15 year-olds, the CIM Health is still awaiting an opinion this month from the Higher Health Council, specify the ministers.
–
